Neubase Therapeutics (NBSE) Stock Price, News & Analysis
Company Description
Neubase Therapeutics (NASDAQ: NBSE) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $1.4M, ranking #7,217 among all listed U.S. companies by market cap.
NBSE stock has declined 100.0% over the past year. Shares last traded at $0.3780.
This page provides a comprehensive overview of NBSE stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neubase Therapeutics (NBSE) stock last traded at $0.3780. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.4M, NBSE is classified as a micro-cap stock with approximately 3.8M shares outstanding.
NBSE Rankings
Latest News
Neubase Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, private placement, offering, stock split, conferences. View all NBSE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NBSE Company Profile & Sector Positioning
Neubase Therapeutics (NBSE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.